Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 50041960
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419356(CHEMBL1916288)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419568(CHEMBL1934415)
Affinity DataIC50: 32nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419565(CHEMBL1934418)
Affinity DataIC50: 40nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419355(CHEMBL1916282)
Affinity DataIC50: 79nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419577(CHEMBL1934414)
Affinity DataIC50: 79nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 158nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419569(CHEMBL1934413)
Affinity DataIC50: 200nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419566(CHEMBL1934417)
Affinity DataIC50: 316nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419575(CHEMBL1934422)
Affinity DataIC50: 316nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419570(CHEMBL1934271)
Affinity DataIC50: 398nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419573(CHEMBL1934267)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419563(CHEMBL1934423)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419571(CHEMBL1934270)
Affinity DataIC50: 1.59E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419567(CHEMBL1934416)
Affinity DataIC50: 2.51E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419564(CHEMBL1934421)
Affinity DataIC50: 3.16E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419572(CHEMBL1934269)
Affinity DataIC50: 3.16E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419578(CHEMBL1934268)
Affinity DataIC50: 6.31E+3nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
LigandPNGBDBM50419355(CHEMBL1916282)
Affinity DataIC50: 7.94E+3nMAssay Description:Inhibition of OATP1B1 transporterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419576(CHEMBL1934419)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419561(CHEMBL1934426)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419562(CHEMBL1934424)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419574(CHEMBL1934266)
Affinity DataIC50: 2.51E+4nMAssay Description:Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed